|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li C, Chen J, Zhang K, Feng B, Wang R and
Chen L: Progress and prospects of long noncoding RNAs (lncRNAs) in
hepatocellular carcinoma. Cell Physiol Biochem. 36:423–434. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hao K, Luk JM, Lee NP, Mao M, Zhang C,
Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC and Poon RT: Predicting
prognosis in hepatocellular carcinoma after curative surgery with
common clinicopathologic parameters. BMC cancer. 9:3892009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Song YX, Ma B, Wang JJ, Sun JX,
Chen XW, Zhao JH, Yang YC and Wang ZN: Regulatory roles of
non-coding RNAS in colorectal cancer. Int J Mol Sci.
16:19886–19919. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Kong X, Zhang J, Luo Q, Li X and
Fang L: MiRNA-26b inhibits proliferation by targeting PTGS2 in
breast cancer. Cancer Cell Int. 13:72013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Wu J, Zheng J, Li Y, Yang T, Hu G,
Dai J, Yang Q, Dai L and Jiang Y: Altered miRNA expression profiles
and miR-1a associated with urethane-induced pulmonary
carcinogenesis. Toxicol Sci. 135:63–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Zhang X, Li H, Yu J and Ren X: The
role of miRNA-29 family in cancer. Eur J Cell Biol. 92:123–128.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng L, Pu J, Qi T, Qi M, Li D, Xiang X,
Huang K and Tong Q: miRNA-145 targets v-ets erythroblastosis virus
E26 oncogene homolog 1 to suppress the invasion, metastasis, and
angiogenesis of gastric cancer cells. Mol Cancer Res. 11:182–193.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin CP, Choi YJ, Hicks GG and He L: The
emerging functions of the p53-miRNA network in stem cell biology.
Cell cycle. 11:2063–2072. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roderburg C, Luedde M, Cardenas D Vargas,
Vucur M, Mollnow T, Zimmermann HW, Koch A, Hellerbrand C,
Weiskirchen R, Frey N, et al: miR-133a mediates TGF-β-dependent
derepression of collagen synthesis in hepatic stellate cells during
liver fibrosis. J Hepatol. 58:736–742. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh RP, Massachi I, Manickavel S, Singh
S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH and
Rehimi H: The role of miRNA in inflammation and autoimmunity.
Autoimmun Rev. 12:1160–1165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishibashi M, Kogo R, Shibata K, Sawada G,
Takahashi Y, Kurashige J, Akiyoshi S, Sasaki S, Iwaya T, Sudo T, et
al: Clinical significance of the expression of long non-coding RNA
HOTAIR in primary hepatocellular carcinoma. Oncol Rep. 29:946–950.
2013.PubMed/NCBI
|
|
15
|
Zhang J, Zhang P, Wang L, Piao HL and Ma
L: Long non-coding RNA HOTAIR in carcinogenesis and metastasis.
Acta Biochim Biophys Sin (Shanghai). 46:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding C, Cheng S, Yang Z, Lv Z, Xiao H, Du
C, Peng C, Xie H, Zhou L, Wu J and Zheng S: Long non-coding RNA
HOTAIR promotes cell migration and invasion via down-regulation of
RNA binding motif protein 38 in hepatocellular carcinoma cells. Int
J Mol Sci. 15:4060–4076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Toffanin S, Villanueva A and Llovet JM:
miRNA delivery: Emerging therapy for hepatocellular carcinoma.
Gastroenterology. 138:1202–1204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Borel F, Konstantinova P and Jansen PL:
Diagnostic and therapeutic potential of miRNA signatures in
patients with hepatocellular carcinoma. J Hepatol. 56:1371–1383.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Geng YJ, Xie SL, Li Q, Ma J and Wang GY:
Large intervening non-coding RNA HOTAIR is associated with
hepatocellular carcinoma progression. J Int Med Res. 39:2119–2128.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao JZ, Li J, Du JL and Li XL: Long
non-coding RNA HOTAIR is a marker for hepatocellular carcinoma
progression and tumor recurrence. Oncol Lett. 11:1791–1798.
2016.PubMed/NCBI
|
|
21
|
Zhao J, Greene CM, Gray SG and Lawless MW:
Long noncoding RNAs in liver cancer: What we know in 2014. Expert
Opin Ther Targets. 18:1207–1218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsang WP and Kwok TT: Riboregulator H19
induction of MDR1-associated drug resistance in human
hepatocellular carcinoma cells. Oncogene. 26:4877–4881. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie H, Ma H and Zhou D: Plasma HULC as a
promising novel biomarker for the detection of hepatocellular
carcinoma. Biomed Res Int. 2013:1361062013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du Y, Kong G, You X, Zhang S, Zhang T, Gao
Y, Ye L and Zhang X: Elevation of highly up-regulated in liver
cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell
proliferation via down-regulating p18. J Biol Chem.
287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li G, Zhang H, Wan X, Yang X, Zhu C, Wang
A, He L, Miao R, Chen S and Zhao H: Long noncoding RNA plays a key
role in metastasis and prognosis of hepatocellular carcinoma.
Biomed Res Int. 2014:7805212014.PubMed/NCBI
|
|
28
|
Huang J, Zhang X, Zhang M, Zhu JD, Zhang
YL, Lin Y, Wang KS, Qi XF, Zhang Q, Liu GZ, et al: Up-regulation of
DLK1 as an imprinted gene could contribute to human hepatocellular
carcinoma. Carcinogenesis. 28:1094–1103. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Braconi C, Kogure T, Valeri N, Huang N,
Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM and Patel T:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP,
Wang F and Sun SH: Repression of the long noncoding RNA-LET by
histone deacetylase 3 contributes to hypoxia-mediated metastasis.
Mol Cell. 49:1083–1096. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuan SX, Yang F, Yang Y, Tao QF, Zhang J,
Huang G, Yang Y, Wang RY, Yang S, Huo XS, et al: Long noncoding RNA
associated with microvascular invasion in hepatocellular carcinoma
promotes angiogenesis and serves as a predictor for hepatocellular
carcinoma patients' poor recurrence-free survival after
hepatectomy. Hepatology. 56:2231–2241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang
Y, Tang GN, Zhou WP and Sun SH: Hepatitis B virus X protein
(HBx)-related long noncoding RNA (lncRNA) down-regulated expression
by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by
targeting the intermediate filament protein vimentin. Hepatology.
57:1882–1892. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang F, Zhang L, Huo XS, Yuan JH, Xu D,
Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, et al: Long noncoding
RNA high expression in hepatocellular carcinoma facilitates tumor
growth through enhancer of zeste homolog 2 in humans. Hepatology.
54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen B, Yu M, Chang Q, Lu Y, Thakur C, Ma
D, Yi Z and Chen F: Mdig de-represses H19 large intergenic
non-coding RNA (lincRNA) by down-regulating H3K9me3 and
heterochromatin. Oncotarget. 4:1427–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hajjari M and Salavaty A: HOTAIR: An
oncogenic long non-coding RNA in different cancers. Cancer Biol
Med. 12:1–9. 2015.PubMed/NCBI
|
|
36
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He S, Liu S and Zhu H: The sequence,
structure and evolutionary features of HOTAIR in mammals. BMC Evol
Biol. 11:1022011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tano K and Akimitsu N: Long non-coding
RNAs in cancer progression. Front Genet. 3:2192012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kaneko S, Li G, Son J, Xu CF, Margueron R,
Neubert TA and Reinberg D: Phosphorylation of the PRC2 component
Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.
Gene Dev. 24:2615–2620. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu Y, Zhang L, Wang Y, Li H, Ren X, Wei F,
Yu W, Wang X, Zhang L, Yu J and Hao X: Long noncoding RNA HOTAIR
involvement in cancer. Tumour Biol. 35:9531–9538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu H, Zeng H, Dong A, Li F, He H,
Senisterra G, Seitova A, Duan S, Brown PJ, Vedadi M, et al:
Structure of the catalytic domain of EZH2 reveals conformational
plasticity in cofactor and substrate binding sites and explains
oncogenic mutations. PLoS One. 8:e837372013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kirmizis A, Bartley SM, Kuzmichev A,
Margueron R, Reinberg D, Green R and Farnham PJ: Silencing of human
polycomb target genes is associated with methylation of histone H3
Lys 27. Gene Dev. 18:1592–1605. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shi Y, Lan F, Matson C, Mulligan P,
Whetstine JR, Cole PA, Casero RA and Shi Y: Histone demethylation
mediated by the nuclear amine oxidase homolog LSD1. Cell.
119:941–953. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yao Y, Li J and Wang L: Large intervening
non-coding RNA HOTAIR is an indicator of poor prognosis and a
therapeutic target in human cancers. Int J Mol Sci. 15:18985–18999.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zimonjic DB and Popescu NC: Role of DLC1
tumor suppressor gene and MYC oncogene in pathogenesis of human
hepatocellular carcinoma: Potential prospects for combined targeted
therapeutics (review). Int J Oncol. 41:393–406. 2012.PubMed/NCBI
|
|
47
|
Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD,
Qin YY, Gong W and Quan ZW: Long non-coding RNA HOTAIR, a c-Myc
activated driver of malignancy, negatively regulates miRNA-130a in
gallbladder cancer. Mol Cancer. 13:1562014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang L, Zhang X, Jia LT, Hu SJ, Zhao J,
Yang JD, Wen WH, Wang Z, Wang T, Zhao J, et al: c-Myc-mediated
epigenetic silencing of MicroRNA-101 contributes to dysregulation
of multiple pathways in hepatocellular carcinoma. Hepatology.
59:1850–1863. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
An J, Wu M, Xin X, Lin Z, Li X, Zheng Q,
Gui X, Li T, Pu H, Li H and Lu D: Inflammatory related gene IKKα,
IKKβ, IKKγ cooperates to determine liver cancer stem cells
progression by altering telomere via heterochromatin protein
1-HOTAIR axis. Oncotarget. 7:50131–50149. 2016.PubMed/NCBI
|
|
50
|
Chiyomaru T, Yamamura S, Fukuhara S,
Yoshino H, Kinoshita T, Majid S, Saini S, Chang I, Tanaka Y,
Enokida H, et al: Genistein inhibits prostate cancer cell growth by
targeting miR-34a and oncogenic HOTAIR. PLoS One. 8:e703722013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chiyomaru T, Fukuhara S, Saini S, Majid S,
Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, et
al: Long non-coding RNA HOTAIR is targeted and regulated by miR-141
in human cancer cells. J Biol Chem. 289:12550–12565. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu SM, Ai HW, Zhang DY, Han XQ, Pan Q, Luo
FL and Zhang XL: MiR-141 targets ZEB2 to suppress HCC progression.
Tumour Biol. 35:9993–9997. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xue J, Niu YF, Huang J, Peng G, Wang LX,
Yang YH and Li YQ: miR-141 suppresses the growth and metastasis of
HCC cells by targeting E2F3. Tumour Biol. 35:12103–12107. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan
J, Li Q, Zhang Y, Ding Y, Chen B and Chen L: MiR-141 suppresses the
migration and invasion of HCC cells by targeting Tiam1. PLoS One.
9:e883932014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lin L, Liang H, Wang Y, Yin X, Hu Y, Huang
J, Ren T, Xu H, Zheng L and Chen X: microRNA-141 inhibits cell
proliferation and invasion and promotes apoptosis by targeting
hepatocyte nuclear factor-3β in hepatocellular carcinoma cells. BMC
cancer. 14:8792014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yang G, Zhang S, Gao F, Liu Z, Lu M, Peng
S, Zhang T and Zhang F: Osteopontin enhances the expression of
HOTAIR in cancer cells via IRF1. Biochim Biophys Acta.
1839:837–848. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Qin L: Osteopontin is a promoter for
hepatocellular carcinoma metastasis: A summary of 10 years of
studies. Front Med. 8:24–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Dong Q, Zhu X, Dai C, Zhang X, Gao X, Wei
J, Sheng Y, Zheng Y, Yu J, Xie L, et al: Osteopontin promotes
epithelial-mesenchymal transition of hepatocellular carcinoma
through regulating vimentin. Oncotarget. 7:12997–13012.
2016.PubMed/NCBI
|
|
59
|
Alves C Padua, Fonseca AS, Muys BR, de
Barros E Lima Bueno R, Bürger MC, De Souza JE, Valente V, Zago MA
and Silva WA Jr: Brief report: The lincRNA Hotair is required for
epithelial-to-mesenchymal transition and stemness maintenance of
cancer cell lines. Stem cells. 31:2827–2832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhao W, An Y, Liang Y and Xie XW: Role of
HOTAIR long noncoding RNA in metastatic progression of lung cancer.
Eur Rev Med Pharmacol Sci. 18:1930–1936. 2014.PubMed/NCBI
|
|
61
|
Yang MC, Wang CJ, Liao PC, Yen CJ and Shan
YS: Hepatic stellate cells secretes type I collagen to trigger
epithelial mesenchymal transition of hepatoma cells. Am J Cancer
Res. 4:751–763. 2014.PubMed/NCBI
|
|
62
|
van Zijl F, Zulehner G, Petz M, Schneller
D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H and Mikulits
W: Epithelial-mesenchymal transition in hepatocellular carcinoma.
Future Oncol. 5:1169–1179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li H, An J, Wu M, Zheng Q, Gui X, Li T, Pu
H and Lu D: LncRNA HOTAIR promotes human liver cancer stem cell
malignant growth through downregulation of SETD2. Oncotarget.
6:27847–27864. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Green DR and Levine B: To be or not to be?
How selective autophagy and cell death govern cell fate. Cell.
157:65–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yang L, Zhang X, Li H and Liu J: The long
noncoding RNA HOTAIR activates autophagy by upregulating ATG3 and
ATG7 in hepatocellular carcinoma. Mol Biosyst. 12:2605–2612. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Au SL, Wong CC, Lee JM, Fan DN, Tsang FH,
Ng IO and Wong CM: Enhancer of zeste homolog 2 epigenetically
silences multiple tumor suppressor microRNAs to promote liver
cancer metastasis. Hepatology. 56:622–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Gao SB, Xu B, Ding LH, Zheng QL, Zhang L,
Zheng QF, Li SH, Feng ZJ, Wei J, Yin ZY, et al: The functional and
mechanistic relatedness of EZH2 and menin in hepatocellular
carcinoma. J Hepatol. 61:832–839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kirmizis A, Bartley SM and Farnham PJ:
Identification of the polycomb group protein SU(Z)12 as a potential
molecular target for human cancer therapy. Mol Cancer Ther.
2:113–121. 2003.PubMed/NCBI
|
|
69
|
Zhao ZK, Dong P, Gu J, Chen L, Zhuang M,
Lu WJ, Wang DR and Liu YB: Overexpression of LSD1 in hepatocellular
carcinoma: A latent target for the diagnosis and therapy of
hepatoma. Tumour Biol. 34:173–180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhao ZK, Yu HF, Wang DR, Dong P, Chen L,
Wu WG, Ding WJ and Liu YB: Overexpression of lysine specific
demethylase 1 predicts worse prognosis in primary hepatocellular
carcinoma patients. World J Gastroenterol. 18:6651–6656. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ye P, Wang T, Liu WH, Li XC, Tang LJ and
Tian FZ: Enhancing HOTAIR/MiR-10b drives normal liver stem cells
toward a tendency to malignant transformation through inducing
epithelial- to-mesenchymal transition. Rejuvenation Res.
18:332–340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW,
Jin HY, Zhang Y, Li Q and Hua KQ: Overexpression of long non-coding
RNA HOTAIR predicts poor patient prognosis and promotes tumor
metastasis in epithelial ovarian cancer. Gynecol Oncol.
134:121–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ono H, Motoi N, Nagano H, Miyauchi E,
Ushijima M, Matsuura M, Okumura S, Nishio M, Hirose T, Inase N and
Ishikawa Y: Long noncoding RNA HOTAIR is relevant to cellular
proliferation, invasiveness, and clinical relapse in small-cell
lung cancer. Cancer Med. 3:632–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhou X, Chen J and Tang W: The molecular
mechanism of HOTAIR in tumorigenesis, metastasis, and drug
resistance. Acta Biochim Biophys Sin (Shanghai). 46:1011–1015.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY,
Xue WQ, Chen YB, Zhang Y and Jia WH: HOTAIR, a prognostic factor in
esophageal squamous cell carcinoma, inhibits WIF-1 expression and
activates Wnt pathway. Cancer Sci. 104:1675–1682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Loewen G, Jayawickramarajah J, Zhuo Y and
Shan B: Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol.
7:902014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang H, Cai K, Wang J, Wang X, Cheng K,
Shi F, Jiang L, Zhang Y and Dou J: MiR-7, inhibited indirectly by
lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of
breast cancer stem cells by downregulating the STAT3 pathway. Stem
Cells. 32:2858–2868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Garcia-Irigoyen O, Latasa MU, Carotti S,
Uriarte I, Elizalde M, Urtasun R, Vespasiani-Gentilucci U, Morini
S, Benito P, Ladero JM, et al: Matrix metalloproteinase 10
contributes to hepatocarcinogenesis in a novel crosstalk with the
stromal derived factor 1/C-X-C chemokine receptor 4 axis.
Hepatology. 62:166–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang Y, Shen Y, Cao B, Yan A and Ji H:
Elevated expression levels of androgen receptors and matrix
metalloproteinase-2 and −9 in 30 cases of hepatocellular carcinoma
compared with adjacent tissues as predictors of cancer invasion and
staging. Exp Ther Med. 9:905–908. 2015.PubMed/NCBI
|
|
80
|
Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ,
Huang L, Yu PF and Cheng XD: Knockdown of long non-coding RNA
HOTAIR suppresses tumor invasion and reverses
epithelial-mesenchymal transition in gastric cancer. Int J Biol
Sci. 9:587–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhang H, Diab A, Fan H, Mani SK, Hullinger
R, Merle P and Andrisani O: PLK1 and HOTAIR accelerate proteasomal
degradation of SUZ12 and ZNF198 during Hepatitis B virus-induced
liver carcinogenesis. Cancer Res. 75:2363–2374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Bhan A and Mandal SS: LncRNA HOTAIR: A
master regulator of chromatin dynamics and cancer. Biochim Biophys
Acta. 1856:151–164. 2015.PubMed/NCBI
|
|
83
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Xing CY, Hu XQ, Xie FY, Yu ZJ, Li HY, Bin
Zhou, Wu JB, Tang LY and Gao SM: Long non-coding RNA HOTAIR
modulates c-KIT expression through sponging miR-193a in acute
myeloid leukemia. FEBS Lett. 589:1981–1987. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Li B, Huang P, Qiu J, Liao Y, Hong J and
Yuan Y: MicroRNA-130a is down-regulated in hepatocellular carcinoma
and associates with poor prognosis. Med Oncol. 31:2302014.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Liu Y, Ren F, Luo Y, Rong M, Chen G and
Dang Y: Down-regulation of MiR-193a-3p dictates deterioration of
HCC: A Clinical real-time qRT-PCR study. Med Sci Monit.
21:2352–2360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Kladi-Skandali A, Michaelidou K, Scorilas
A and Mavridis K: Long noncoding RNAs in digestive system
malignancies: A novel class of cancer biomarkers and therapeutic
targets? Gastroenterol Res Pract. 2015.3198612015.PubMed/NCBI
|
|
88
|
Fu WM, Zhu X, Wang WM, Lu YF, Hu BG, Wang
H, Liang WC, Wang SS, Ko CH, Waye MM, et al: Hotair mediates
hepatocarcinogenesis through suppressing miRNA-218 expression and
activating P14 and P16 signaling. J Hepatol. 63:886–895. 2015.
View Article : Google Scholar : PubMed/NCBI
|
